Prosecution Insights
Last updated: April 19, 2026
Application No. 15/289,299

PULSE WAVE ANALYZER

Final Rejection §103
Filed
Oct 10, 2016
Examiner
TOTH, KAREN E
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Nihon Kohden Corporation
OA Round
10 (Final)
47%
Grant Probability
Moderate
11-12
OA Rounds
4y 12m
To Grant
71%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allow Rate
350 granted / 749 resolved
-23.3% vs TC avg
Strong +25% interview lift
Without
With
+24.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 12m
Avg Prosecution
72 currently pending
Career history
821
Total Applications
across all art units

Statute-Specific Performance

§101
13.3%
-26.7% vs TC avg
§103
36.5%
-3.5% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
27.8%
-12.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 749 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 3, 5, 8, 8, 9, 11, 13, 16 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sugo (US 2011/0060531) in view of Chang (US 5385149). Regarding claims 1 and 9, Sugo discloses a pulse wave analyzer and a method of its use comprising: a controller (element 40) configured to: acquire a pulse wave of the subject, the pulse wave comprising a plurality of continuous unit pulse waves (paragraph [0056]); acquire an electrocardiogram of the subject (paragraph [0055]); acquire respiration information of the subject for at least one respiratory period (paragraphs [0064]-[0069]); determine a selection criterion range based on the electrocardiogram and also based on the respiration information (paragraph [0055], the ECG is used to provide reference point based on identification of R waves that are used to coordinate further analysis of pulse waves/stroke volume; paragraph [0071], the evaluation of pulse waves only takes place if the evaluation of respiration information also yields a “yes”); select unit pulse waves that meet the selection criterion range (paragraphs [0072]-[0077]), calculate a respiratory variation from the selected unit pulse waves (paragraph [0080]); and display the calculated respiratory variation on a display (paragraphs [0030]-[0032]). Sugo does not call for the analyzer to calculate, for each of the unit pulse waves that has an immediately preceding unit pulse wave, a ratio between an amplitude of the unit pulse wave and an amplitude of the immediately preceding unit pulse wave and to select unit pulse waves that have calculated ratios within the selection criterion range, and eliminate unit pulse waves that have calculated ratios outside the selection criterion range; Chang teaches a pulse wave analyzer comprising a processor and memory (column 2, lines 56-66) configured to acquire pulse waves of a subject (column 2, lines 53-60) and select a “unit pulse wave” by comparing amplitudes of a plurality of “unit pulse wave” with each other and eliminating “unit pulse wave” having a variation in amplitude relative to an immediately preceding pulse wave that is equal to or greater than a “selection criterion” (column 2, lines 30-44). It would have been obvious to one of ordinary skill in the art at the time the invention was made to have followed Sugo and used comparison of amplitudes of adjacent waves to select the “unit pulse wave”, as taught by Chang, in order to ensure that the wave having the ultimate level of the desired attribute is selected. The Examiner notes that the claims as amended present two distinct options for the selection criterion range: (1) based on the pulse wave and also based on the respiration information where a size of the range is inversely related to a number of unit pulse waves per respiratory period, OR (2) based on the electrocardiogram and also based on the respiration information. Regarding claims 3, 5, 11, and 13, Sugo further discloses that the controller is further configured: to calculate a heart rate contained in one respiratory period detected from the electrocardiogram in a predetermined time period (paragraph [0055]), and a respiration rate detected from the respiration information in the predetermined time period (paragraph [0064]), and to determine the selection criterion range based on the calculated heart rate (paragraph [0062] calls for calculation of esSV per figure 11, which uses heart rate; per paragraphs [0064]-[0067]) the measured variation is a function of the calculated esSV and the thresholds placed on it are also a function of the calculated esSV and thus a function of HR). Regarding claims 8 and 16, Sugo further discloses that the controller is further configured to display a graph representing the pulse wave and a mark on the graph in the vicinity of a pulse pressure variation (PPV) value and a PPV trend of the pulse wave when a number of unit pulse waves not selected is equal to or higher than a given level (figure 9; the Examiner notes that “a mark” is any mark, any mark on the display is “in the vicinity of” trends thereon, and in the absence of any specificity as to a particular “number” the number could be zero such that the “mark” is always displayed). Claims 17 and 18 are rejected under 35 U.S.C. 103 as being unpatentable over Sugo and Chang, as applied above, and further in view of Sugo’544 (US 2014/0121544). Sugo discloses the presence of an alarm (figure 1 and 8) but does not discuss its use. Sugo’544 discloses a similar pulse wave analyzer configured to use its alarm to notify a user of an “abnormal” value (paragraph [0075]). It would have been obvious to one of ordinary skill in the art at the time the invention was filed to have made the device of Sugo, as modified, and generated an alarm to notify a user of an abnormal respiratory variation, as taught by Sugo’544, because Sugo already discloses the presence of an alarm but not its use and notification of abnormal values allows intervention for adverse conditions. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: The prior art of record fails to anticipate or make obvious the invention of claim 7, including, inter-alia, a pulse wave analyzer configured to acquire a plurality of continuous unit pulse waves, an electrocardiogram, and respiration information; select a plurality of unit pulse waves by determining an amplitude of each of the unit pulse waves, calculating an average amplitude of the plurality of unit pulse waves and a standard deviation of the amplitudes of the unit pulse waves in a predetermined time period, and eliminating unit pulse waves having an amplitude that is equal to or less than a lower limit, or that is equal to or greater than an upper limit, wherein the lower limit and the upper limit define a range of amplitude values inclusive of the average amplitude, and are determined based on the standard deviation relative to the average amplitude; and calculate and display a respiratory variation from the selected unit pulse waves, in combination with all other limitations in the claim. Sugo discloses a similar system, as discussed in previous Office Actions, but the Board of Appeals determined on 6 August 2025 that Sugo’s upper and lower limits are not based on standard deviation relative to an average amplitude. The prior art of record fails to anticipate or make obvious the invention of claim 19, including, inter-alia, a pulse wave analyzer configured to acquire a plurality of continuous unit pulse waves, an electrocardiogram, and respiration information for at least one respiratory period; determine a ratio threshold based on the pulse wave or the electrocardiogram, and also based on the respiration information; calculate, for each of the unit pulse waves that has an immediately preceding unit pulse wave, a ratio between an amplitude of the unit pulse wave and an amplitude of the immediately preceding unit pulse wave; select unit pulse waves that have calculated ratios less than the determined ratio threshold, and eliminate unit pulse waves that have calculated ratios greater than or equal to the determined ratio threshold; and calculate and display a respiratory variation from the selected unit pulse waves, in combination with all other limitations in the claims. Kitajima, applied in previous Office Actions, uses a ratio between amplitudes of adjacent pulse waves as a selection criteria, but does not use the selection criteria for eliminating unit pulse waves. Response to Arguments Applicant's arguments filed 25 February 2026 have been fully considered but they are not persuasive. Regarding the art rejections, Applicant argues only that Sugo is cited as teaching the selection criterion range being selected using the “first alternative (pulse wave and respiratory information)” but does not teach the size of that selection range being inversely related to a number of unit pulse waves per respiratory period. Applicant’s attention is drawn to page 3 of the Office Action mailed 2 December 2025, reproduced in part here: PNG media_image1.png 266 686 media_image1.png Greyscale This is also the text of the rejection presented above. Sugo clearly teaches the electrocardiogram as being involved in determining the selection criterion range, as noted in Applicant’s remarks despite Applicant somehow interpreting the clear description of “based on the electrocardiogram” and citing text describing use of an electrocardiogram as being an attempt to teach use of pulse waves - a different, alternative limitation. As Applicant’s argument is unrelated to the rejection of the claims, the assertion that Sugo fails to teach limitations which it is not relied upon to teach while not addressing the limitations that Sugo is cited as disclosing is unpersuasive in overcoming the rejection as a whole, and the claims remain rejected. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KAREN E TOTH whose telephone number is (571)272-6824. The examiner can normally be reached Mon - Fri 9a-6p. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at 571-272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KAREN E TOTH/Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Oct 10, 2016
Application Filed
Sep 11, 2018
Non-Final Rejection — §103
Jan 11, 2019
Response Filed
Mar 27, 2019
Final Rejection — §103
Jul 01, 2019
Response after Non-Final Action
Aug 27, 2019
Request for Continued Examination
Aug 28, 2019
Response after Non-Final Action
Mar 26, 2020
Non-Final Rejection — §103
Sep 22, 2020
Response Filed
Nov 05, 2020
Final Rejection — §103
Feb 09, 2021
Examiner Interview Summary
Feb 09, 2021
Applicant Interview (Telephonic)
Feb 15, 2021
Request for Continued Examination
Feb 16, 2021
Response after Non-Final Action
Dec 10, 2021
Non-Final Rejection — §103
Mar 11, 2022
Response Filed
May 20, 2022
Final Rejection — §103
Aug 24, 2022
Examiner Interview Summary
Aug 24, 2022
Applicant Interview (Telephonic)
Sep 26, 2022
Request for Continued Examination
Oct 05, 2022
Response after Non-Final Action
Mar 22, 2023
Non-Final Rejection — §103
Jun 21, 2023
Interview Requested
Jun 28, 2023
Examiner Interview Summary
Jun 28, 2023
Applicant Interview (Telephonic)
Jul 31, 2023
Response Filed
Oct 17, 2023
Final Rejection — §103
Jan 25, 2024
Notice of Allowance
Mar 08, 2024
Response after Non-Final Action
Mar 15, 2024
Response after Non-Final Action
May 28, 2024
Response after Non-Final Action
Jul 16, 2024
Response after Non-Final Action
Jul 17, 2024
Response after Non-Final Action
Jul 18, 2024
Response after Non-Final Action
Jul 18, 2024
Response after Non-Final Action
Aug 05, 2025
Response after Non-Final Action
Oct 02, 2025
Request for Continued Examination
Oct 10, 2025
Response after Non-Final Action
Nov 26, 2025
Non-Final Rejection — §103
Feb 25, 2026
Response Filed
Mar 09, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12588842
SYSTEMS AND METHODS FOR MEASURING OXYGEN IN A PATIENT'S BLOODSTREAM
2y 5m to grant Granted Mar 31, 2026
Patent 12514979
FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL
2y 5m to grant Granted Jan 06, 2026
Patent 12490936
Smart Interface Cable for Coupling a Diagnostic Medical Device With a Medical Measurement System
2y 5m to grant Granted Dec 09, 2025
Patent 12465338
VACUUM-ASSISTED SOFT TISSUE BIOPSY DEVICE
2y 5m to grant Granted Nov 11, 2025
Patent 12390133
SENSOR ASSEMBLY APPARATUS AND METHODS FOR CONTINUOUS GLUCOSE MONITORS
2y 5m to grant Granted Aug 19, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

11-12
Expected OA Rounds
47%
Grant Probability
71%
With Interview (+24.6%)
4y 12m
Median Time to Grant
High
PTA Risk
Based on 749 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month